Search Login Register

Buruli Ulcer Summary

69 relevant articles (5 outcomes, 5 trials/studies) found for this Disease

Description: A lesion in the skin and subcutaneous tissues due to infections by MYCOBACTERIUM ULCERANS. It was first reported in Uganda, Africa.

Also Known As: Infections, Mycobacterium ulcerans; Infection, Mycobacterium ulcerans; Mycobacterium ulcerans Infections; Ulcer, Buruli; Mycobacterium ulcerans Infection

Key Drugs and Agents for Buruli Ulcer

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Rifampin (Rifampicin) : 3 outcomes in 15 results : FDA 10 Generic
  2. Streptomycin (Streptomycin Sulfate) : 2 outcomes in 7 results : FDA 7
  3. DNA (Deoxyribonucleic Acid) : 1 outcome in 5 results : IBA
  4. Antigens : 1 outcome in 3 results : IBA
  5. A-Form DNA (A-DNA) : 1 outcome in 1 result : IBA
  6. Heparin (Liquaemin) : 1 outcome in 1 result : FDA 69 Generic
  7. mycolactone : 1 study in 10 results : IBA
  8. mycolactone A : 1 study in 5 results : IBA
  9. Clofazimine (Lamprene) : 1 study in 2 results : FDA 1
  10. Tuberculin (PPD) : 1 study in 1 result : IBA
Show All >>

Diseases Related to Buruli Ulcer

  1. Thrombosis (Thrombus)
  2. Buruli Ulcer
  3. Pain (Aches)
  4. Infection
  5. Skin Diseases
Show All >>

Key Therapies for Buruli Ulcer

Efficacy Chart >>
  1. Transplants (Transplant) : 2 results
  2. Hyperbaric Oxygenation : 2 results
  3. Autologous Transplantation (Autograft) : 1 result
  4. Therapeutics : 1 result
  5. Drug Therapy (Chemotherapy) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.